Voleon Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.56M Sell
87,557
-279,271
-76% -$23.2M 0.13% 158
2026
Q2
$24.7M Sell
366,828
-158,789
-30% -$10.6M 0.45% 44
2026
Q1
$33M Sell
525,617
-11,655
-2% -$812K 0.71% 22
2025
Q4
$35.7M Buy
537,272
+284,954
+113% +$18.4M 0.77% 15
2025
Q3
$17M Buy
252,318
+184,509
+272% +$14.6M 0.41% 39
2025
Q2
$5.92M Sell
67,809
-9,301
-12% -$729K 0.32% 74
2025
Q1
$5.27M Buy
77,110
+19,188
+33% +$1.57M 0.41% 65
2024
Q4
$4.5M Buy
+57,922
New +$4.29M 0.33% 79
2019
Q3
– Sell
-32,000
Closed -$1.2M – 173
2019
Q2
$1.2M Buy
+32,000
New +$1.01M 0.07% 155

Other funds holding DXCM

Voleon Capital Management's DXCM Position: Q3 2026 in Review

Voleon Capital Management reduced its DexCom (DXCM) stake by 76% in Q3 2026, selling an estimated $23.2M and leaving 87,557 shares worth $7.56M. The position accounts for 0.13% of the portfolio, ranked #158.

Voleon Capital Management first reported a position in DXCM in Q2 2019 and has held it in 9 quarters since. The position peaked at $35.7M in Q4 2025. 1,043 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.

  • Voleon Capital Management held 87,557 shares of DexCom worth $7.56M as of Q3 2026.
  • Voleon Capital Management sold 279,271 DexCom shares in Q3 2026, an estimated $23.2M.
  • DexCom made up 0.13% of Voleon Capital Management's portfolio in Q3 2026, its #158 holding.
  • Voleon Capital Management first reported a position in DexCom in Q2 2019 and has held it in 9 quarters since.
  • Voleon Capital Management's DexCom position peaked at $35.7M in Q4 2025.
  • 1,043 funds tracked by Wall St. Rank held DexCom as of Q3 2026.

Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.